{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:18:19Z","timestamp":1788337099112,"version":"build-2803163510"},"reference-count":57,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>The long-term use of immunosuppressive drugs following kidney transplantation increases the risk of life-threatening infections, malignancies, and, paradoxically, eventual allograft rejection. Therefore, achieving a balance between over-immunosuppression and under-immunosuppression is critical to optimizing patient outcomes. One promising approach is immune cell-based therapy using suppressor immune cells to modulate the immune response more precisely. Among these, regulatory T cells (Tregs) are the most extensively studied and have shown significant potential in the post-transplant setting. Tregs are broadly categorized into thymus-derived and peripherally derived subsets. Physiologically, they play key roles in maintaining immune tolerance, including in autoimmune diseases and within the tumor microenvironment. Their immunosuppressive functions are mediated through both contact-dependent and contact-independent mechanisms. Studies investigating the use of Tregs following kidney transplantation have shown encouraging results. This review summarizes the biology of Tregs and highlights current evidence supporting their role in transplant immunotherapy.<\/jats:p>","DOI":"10.3390\/antib14020049","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T07:04:52Z","timestamp":1750143892000},"page":"49","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?"],"prefix":"10.3390","volume":"14","author":[{"given":"Ahmad","family":"Matarneh","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meet","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Western Reserve Hospital, Cuyahoga Falls, OH 44223, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinna","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Western Reserve Hospital, Cuyahoga Falls, OH 44223, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Karasinski","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurwant","family":"Kaur","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaqar","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0299-9394","authenticated-orcid":false,"given":"Nasrollah","family":"Ghahramani","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naman","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"ref_1","unstructured":"United States Renal Data System (2023). 2023 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e70047","DOI":"10.1111\/apha.70047","article-title":"Calcineurin Inhibitor Associated Nephrotoxicity in Kidney Transplantation\u2014A Transplant Nephrologist\u2019s Perspective","volume":"241","author":"Hansen","year":"2025","journal-title":"Acta Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jceh.2023.05.005","article-title":"Renal Dysfunction After Liver Transplant: Is CNI Nephrotoxicity Overrated","volume":"13","author":"Puri","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101446","DOI":"10.1016\/j.beha.2023.101446","article-title":"Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults","volume":"36","author":"Rubinstein","year":"2023","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tamargo, C.L., and Kant, S. (2023). Pathophysiology of rejection in kidney transplantation. J. Clin. Med., 12.","DOI":"10.3390\/jcm12124130"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ajt.2023.05.005","article-title":"Increased volume of organ offers and decreased efficiency of kidney placement under circle-based kidney allocation","volume":"23","author":"Cron","year":"2023","journal-title":"Am. J. Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.34067\/KID.0002472021","article-title":"Global perspective on kidney transplantation: United States","volume":"2","author":"Wang","year":"2021","journal-title":"Kidney360"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: A systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e251665","DOI":"10.1001\/jamanetworkopen.2025.1665","article-title":"Kidney transplant wait times under waiting list expansion scenarios","volume":"8","author":"UCaldwell","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Cheung, J., Zahorowska, B., Suranyi, M., Wong, J.K., Diep, J., Spicer, S.T., Verma, N.D., Hodgkinson, S.J., and Hall, B.M. (2022). CD4+ CD25+ T regulatory cells in renal transplantation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1017683"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wegrzyn, A.S., Kedzierska, A.E., and Obojski, A. (2023). Identification and classification of distinct surface markers of T regulatory cells. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1055805"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Arjomandnejad, M., Kopec, A.L., and Keeler, A.M. (2022). CAR-T regulatory (CAR-Treg) cells: Engineering and applications. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020287"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Santamaria, J.C., Borelli, A., and Irla, M. (2021). Regulatory T cell heterogeneity in the thymus: Impact on their functional activities. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.643153"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/eji.202149358","article-title":"Regulatory T-cell development in the tumor microenvironment","volume":"52","author":"Itahashi","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"108469","DOI":"10.1016\/j.intimp.2021.108469","article-title":"Immunotherapy of cancer by targeting regulatory T cells","volume":"104","author":"Chen","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K., Chang, H.D., Bopp, T., and Schmitt, E. (2007). Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol., 5.","DOI":"10.1371\/journal.pbio.0050038"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102888","DOI":"10.1016\/j.jaut.2022.102888","article-title":"Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells","volume":"132","author":"McGovern","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","article-title":"Engineering the next generation of cell-based therapeutics","volume":"21","author":"Bashor","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Jiang, Q., Yang, G., Liu, Q., Wang, S., and Cui, D. (2021). Function and role of regulatory T cells in rheumatoid arthritis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.626193"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"110418","DOI":"10.1016\/j.intimp.2023.110418","article-title":"T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases","volume":"121","author":"Chen","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Grover, P., Goel, P.N., and Greene, M.I. (2021). Regulatory T cells: Regulation of identity and function. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.750542"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.immuni.2014.05.019","article-title":"MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells","volume":"41","author":"Okoye","year":"2014","journal-title":"Immunity"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.2300224","article-title":"Integrating T cell activation signals to regulate gene expression through cyclosporin-sensitive NFAT","volume":"211","author":"Kaye","year":"2023","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12974-022-02441-x","article-title":"The cytokines interleukin-6 and interferon-\u03b1 induce distinct microglia phenotypes","volume":"19","author":"West","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ajt.15700","article-title":"Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation","volume":"20","author":"Whitehouse","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Oberholtzer, N., Atkinson, C., and Nadig, S.N. (2021). Adoptive transfer of regulatory immune cells in organ transplantation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.631365"},{"key":"ref_31","first-page":"e107","article-title":"Clinical efficacy of regulatory T-cell therapy in kidney transplantation: First-in-human phase I study","volume":"104","author":"Koyama","year":"2020","journal-title":"Transplantation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41581-023-00733-w","article-title":"Regulatory T cells in autoimmune kidney diseases and transplantation","volume":"19","author":"Mikami","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"eabf5264","DOI":"10.1126\/scitranslmed.abf5264","article-title":"Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients","volume":"13","author":"Chen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/ajt.16395","article-title":"Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients","volume":"21","author":"Harden","year":"2021","journal-title":"Am. J. Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101411","DOI":"10.1016\/j.trim.2021.101411","article-title":"Regulatory T cells induce transplant immune tolerance","volume":"67","author":"Lu","year":"2021","journal-title":"Transpl. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): A harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lai, X., Zheng, X., Mathew, J.M., Gallon, L., Leventhal, J.R., and Zhang, Z.J. (2021). Tackling Chronic Kidney Transplant Rejection: Challenges and Promises. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.661643"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical trial of autologous CD4+CD25+CD127\u2212 regulatory T cells in patients with graft-versus-host disease and type 1 diabetes","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Mohseni, Y.R., Tung, S.L., Dudreuilh, C., Lechler, R.I., Fruhwirth, G.O., and Lombardi, G. (2020). The future of regulatory T cell therapy: Promises and challenges of implementing CAR technology. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01608"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Riet, T., and Chmielewski, M. (2022). Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.934343"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Juneja, T., Kazmi, M., Mellace, M., and Saidi, R.F. (2022). Utilization of Treg Cells in Solid Organ Transplantation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.746889"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hu, M., Rogers, N.M., Li, J., Zhang, G.Y., Wang, Y.M., Shaw, K., O\u2019Connell, P.J., and Alexander, S.I. (2021). Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.717594"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.transproceed.2019.11.003","article-title":"Long-Term Kidney Transplant Outcomes: Role of Prolonged-Release Tacrolimus","volume":"52","author":"Banas","year":"2020","journal-title":"Transplant. Proc."},{"key":"ref_45","first-page":"2558","article-title":"Safety of CAR T-cell therapy in kidney transplant recipients","volume":"137","author":"Mamlouk","year":"2021","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2474743","DOI":"10.1080\/0886022X.2025.2474743","article-title":"Factors associated with chronic calcineurin inhibitor nephrotoxicity in children with minimal-change disease","volume":"47","author":"Jin","year":"2025","journal-title":"Ren. Fail."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"153544","DOI":"10.1016\/j.tox.2023.153544","article-title":"Role of cyclosporin A in the treatment of kidney disease and nephrotoxicity","volume":"492","author":"Yu","year":"2023","journal-title":"Toxicology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASN.0000106015.29070.E7","article-title":"Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention","volume":"15","author":"Liu","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"ref_50","first-page":"1","article-title":"Two Decades of Tacrolimus in Renal Transplant: Basic Science and Clinical Evidences","volume":"15","author":"Shrestha","year":"2017","journal-title":"Exp. Clin. Transplant. Off. J. Middle East Soc. Organ Transplant."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/ajt.13541","article-title":"BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12","volume":"16","author":"Hirsch","year":"2016","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Shen, C.L., Wu, B.S., Lien, T.J., Yang, A.H., and Yang, C.Y. (2021). BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection. Viruses, 13.","DOI":"10.3390\/v13030487"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e13399","DOI":"10.1111\/tid.13399","article-title":"T-cell adoptive immunotherapy for BK nephropathy in renal transplantation","volume":"22","author":"Jahan","year":"2020","journal-title":"Transpl. Infect. Dis. Off. J. Transplant. Soc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.ajt.2023.08.005","article-title":"T regulatory cell therapy: The price of specificity","volume":"23","author":"Muckenhuber","year":"2023","journal-title":"Am. J. Transplant."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e221847","DOI":"10.1001\/jamanetworkopen.2022.1847","article-title":"Trends in cost attributable to kidney transplantation evaluation and waiting list management in the United States, 2012\u20132017","volume":"5","author":"Cheng","year":"2022","journal-title":"JAMA Netw. Open"}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/14\/2\/49\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:53:30Z","timestamp":1760032410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/14\/2\/49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":57,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["antib14020049"],"URL":"https:\/\/doi.org\/10.3390\/antib14020049","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}